Code
stringlengths 3
7
| Description
stringlengths 4
228
|
---|---|
T45692S
|
Poisoning by other fibrinolysis-affecting drugs, intentional self-harm, sequela
|
T45693A
|
Poisoning by other fibrinolysis-affecting drugs, assault, initial encounter
|
T45693D
|
Poisoning by other fibrinolysis-affecting drugs, assault, subsequent encounter
|
T45693S
|
Poisoning by other fibrinolysis-affecting drugs, assault, sequela
|
T45694A
|
Poisoning by other fibrinolysis-affecting drugs, undetermined, initial encounter
|
T45694D
|
Poisoning by other fibrinolysis-affecting drugs, undetermined, subsequent encounter
|
T45694S
|
Poisoning by other fibrinolysis-affecting drugs, undetermined, sequela
|
T45695A
|
Adverse effect of other fibrinolysis-affecting drugs, initial encounter
|
T45695D
|
Adverse effect of other fibrinolysis-affecting drugs, subsequent encounter
|
T45695S
|
Adverse effect of other fibrinolysis-affecting drugs, sequela
|
T45696A
|
Underdosing of other fibrinolysis-affecting drugs, initial encounter
|
T45696D
|
Underdosing of other fibrinolysis-affecting drugs, subsequent encounter
|
T45696S
|
Underdosing of other fibrinolysis-affecting drugs, sequela
|
T457X1A
|
Poisoning by anticoagulant antagonists, vitamin K and other coagulants, accidental (unintentional), initial encounter
|
T457X1D
|
Poisoning by anticoagulant antagonists, vitamin K and other coagulants, accidental (unintentional), subsequent encounter
|
T457X1S
|
Poisoning by anticoagulant antagonists, vitamin K and other coagulants, accidental (unintentional), sequela
|
T457X2A
|
Poisoning by anticoagulant antagonists, vitamin K and other coagulants, intentional self-harm, initial encounter
|
T457X2D
|
Poisoning by anticoagulant antagonists, vitamin K and other coagulants, intentional self-harm, subsequent encounter
|
T457X2S
|
Poisoning by anticoagulant antagonists, vitamin K and other coagulants, intentional self-harm, sequela
|
T457X3A
|
Poisoning by anticoagulant antagonists, vitamin K and other coagulants, assault, initial encounter
|
T457X3D
|
Poisoning by anticoagulant antagonists, vitamin K and other coagulants, assault, subsequent encounter
|
T457X3S
|
Poisoning by anticoagulant antagonists, vitamin K and other coagulants, assault, sequela
|
T457X4A
|
Poisoning by anticoagulant antagonists, vitamin K and other coagulants, undetermined, initial encounter
|
T457X4D
|
Poisoning by anticoagulant antagonists, vitamin K and other coagulants, undetermined, subsequent encounter
|
T457X4S
|
Poisoning by anticoagulant antagonists, vitamin K and other coagulants, undetermined, sequela
|
T457X5A
|
Adverse effect of anticoagulant antagonists, vitamin K and other coagulants, initial encounter
|
T457X5D
|
Adverse effect of anticoagulant antagonists, vitamin K and other coagulants, subsequent encounter
|
T457X5S
|
Adverse effect of anticoagulant antagonists, vitamin K and other coagulants, sequela
|
T457X6A
|
Underdosing of anticoagulant antagonist, vitamin K and other coagulants, initial encounter
|
T457X6D
|
Underdosing of anticoagulant antagonist, vitamin K and other coagulants, subsequent encounter
|
T457X6S
|
Underdosing of anticoagulant antagonist, vitamin K and other coagulants, sequela
|
T458X1A
|
Poisoning by other primarily systemic and hematological agents, accidental (unintentional), initial encounter
|
T458X1D
|
Poisoning by other primarily systemic and hematological agents, accidental (unintentional), subsequent encounter
|
T458X1S
|
Poisoning by other primarily systemic and hematological agents, accidental (unintentional), sequela
|
T458X2A
|
Poisoning by other primarily systemic and hematological agents, intentional self-harm, initial encounter
|
T458X2D
|
Poisoning by other primarily systemic and hematological agents, intentional self-harm, subsequent encounter
|
T458X2S
|
Poisoning by other primarily systemic and hematological agents, intentional self-harm, sequela
|
T458X3A
|
Poisoning by other primarily systemic and hematological agents, assault, initial encounter
|
T458X3D
|
Poisoning by other primarily systemic and hematological agents, assault, subsequent encounter
|
T458X3S
|
Poisoning by other primarily systemic and hematological agents, assault, sequela
|
T458X4A
|
Poisoning by other primarily systemic and hematological agents, undetermined, initial encounter
|
T458X4D
|
Poisoning by other primarily systemic and hematological agents, undetermined, subsequent encounter
|
T458X4S
|
Poisoning by other primarily systemic and hematological agents, undetermined, sequela
|
T458X5A
|
Adverse effect of other primarily systemic and hematological agents, initial encounter
|
T458X5D
|
Adverse effect of other primarily systemic and hematological agents, subsequent encounter
|
T458X5S
|
Adverse effect of other primarily systemic and hematological agents, sequela
|
T458X6A
|
Underdosing of other primarily systemic and hematological agents, initial encounter
|
T458X6D
|
Underdosing of other primarily systemic and hematological agents, subsequent encounter
|
T458X6S
|
Underdosing of other primarily systemic and hematological agents, sequela
|
T4591XA
|
Poisoning by unspecified primarily systemic and hematological agent, accidental (unintentional), initial encounter
|
T4591XD
|
Poisoning by unspecified primarily systemic and hematological agent, accidental (unintentional), subsequent encounter
|
T4591XS
|
Poisoning by unspecified primarily systemic and hematological agent, accidental (unintentional), sequela
|
T4592XA
|
Poisoning by unspecified primarily systemic and hematological agent, intentional self-harm, initial encounter
|
T4592XD
|
Poisoning by unspecified primarily systemic and hematological agent, intentional self-harm, subsequent encounter
|
T4592XS
|
Poisoning by unspecified primarily systemic and hematological agent, intentional self-harm, sequela
|
T4593XA
|
Poisoning by unspecified primarily systemic and hematological agent, assault, initial encounter
|
T4593XD
|
Poisoning by unspecified primarily systemic and hematological agent, assault, subsequent encounter
|
T4593XS
|
Poisoning by unspecified primarily systemic and hematological agent, assault, sequela
|
T4594XA
|
Poisoning by unspecified primarily systemic and hematological agent, undetermined, initial encounter
|
T4594XD
|
Poisoning by unspecified primarily systemic and hematological agent, undetermined, subsequent encounter
|
T4594XS
|
Poisoning by unspecified primarily systemic and hematological agent, undetermined, sequela
|
T4595XA
|
Adverse effect of unspecified primarily systemic and hematological agent, initial encounter
|
T4595XD
|
Adverse effect of unspecified primarily systemic and hematological agent, subsequent encounter
|
T4595XS
|
Adverse effect of unspecified primarily systemic and hematological agent, sequela
|
T4596XA
|
Underdosing of unspecified primarily systemic and hematological agent, initial encounter
|
T4596XD
|
Underdosing of unspecified primarily systemic and hematological agent, subsequent encounter
|
T4596XS
|
Underdosing of unspecified primarily systemic and hematological agent, sequela
|
T460X1A
|
Poisoning by cardiac-stimulant glycosides and drugs of similar action, accidental (unintentional), initial encounter
|
T460X1D
|
Poisoning by cardiac-stimulant glycosides and drugs of similar action, accidental (unintentional), subsequent encounter
|
T460X1S
|
Poisoning by cardiac-stimulant glycosides and drugs of similar action, accidental (unintentional), sequela
|
T460X2A
|
Poisoning by cardiac-stimulant glycosides and drugs of similar action, intentional self-harm, initial encounter
|
T460X2D
|
Poisoning by cardiac-stimulant glycosides and drugs of similar action, intentional self-harm, subsequent encounter
|
T460X2S
|
Poisoning by cardiac-stimulant glycosides and drugs of similar action, intentional self-harm, sequela
|
T460X3A
|
Poisoning by cardiac-stimulant glycosides and drugs of similar action, assault, initial encounter
|
T460X3D
|
Poisoning by cardiac-stimulant glycosides and drugs of similar action, assault, subsequent encounter
|
T460X3S
|
Poisoning by cardiac-stimulant glycosides and drugs of similar action, assault, sequela
|
T460X4A
|
Poisoning by cardiac-stimulant glycosides and drugs of similar action, undetermined, initial encounter
|
T460X4D
|
Poisoning by cardiac-stimulant glycosides and drugs of similar action, undetermined, subsequent encounter
|
T460X4S
|
Poisoning by cardiac-stimulant glycosides and drugs of similar action, undetermined, sequela
|
T460X5A
|
Adverse effect of cardiac-stimulant glycosides and drugs of similar action, initial encounter
|
T460X5D
|
Adverse effect of cardiac-stimulant glycosides and drugs of similar action, subsequent encounter
|
T460X5S
|
Adverse effect of cardiac-stimulant glycosides and drugs of similar action, sequela
|
T460X6A
|
Underdosing of cardiac-stimulant glycosides and drugs of similar action, initial encounter
|
T460X6D
|
Underdosing of cardiac-stimulant glycosides and drugs of similar action, subsequent encounter
|
T460X6S
|
Underdosing of cardiac-stimulant glycosides and drugs of similar action, sequela
|
T461X1A
|
Poisoning by calcium-channel blockers, accidental (unintentional), initial encounter
|
T461X1D
|
Poisoning by calcium-channel blockers, accidental (unintentional), subsequent encounter
|
T461X1S
|
Poisoning by calcium-channel blockers, accidental (unintentional), sequela
|
T461X2A
|
Poisoning by calcium-channel blockers, intentional self-harm, initial encounter
|
T461X2D
|
Poisoning by calcium-channel blockers, intentional self-harm, subsequent encounter
|
T461X2S
|
Poisoning by calcium-channel blockers, intentional self-harm, sequela
|
T461X3A
|
Poisoning by calcium-channel blockers, assault, initial encounter
|
T461X3D
|
Poisoning by calcium-channel blockers, assault, subsequent encounter
|
T461X3S
|
Poisoning by calcium-channel blockers, assault, sequela
|
T461X4A
|
Poisoning by calcium-channel blockers, undetermined, initial encounter
|
T461X4D
|
Poisoning by calcium-channel blockers, undetermined, subsequent encounter
|
T461X4S
|
Poisoning by calcium-channel blockers, undetermined, sequela
|
T461X5A
|
Adverse effect of calcium-channel blockers, initial encounter
|
T461X5D
|
Adverse effect of calcium-channel blockers, subsequent encounter
|
T461X5S
|
Adverse effect of calcium-channel blockers, sequela
|
Subsets and Splits
Diabetes Codes E10-E14
The query retrieves and sorts records with "Code" values between 'E10' and 'E14', offering a basic filter of the dataset but not providing significant analytical insights.